Abstract
The article contains sections titled:
| 1. | Introduction |
| 2. | Nonselective Monoamine Reuptake Inhibitors |
| 3. | Selective Serotonin Reuptake Inhibitors (SSRIs) |
| 4. | Monoamine Oxidase Inhibitors (MAOIs) |
| 5. | Other Antidepressants |
References
- 1 P. Charlish: “Mind over matter–prospects for the CNS market”, SCRIP Executive Briefing 14 May 2010, www.scripintelligence.com (accessed: 24 June 2013).
- 2 D. Chancellor: “The depression market”, Nature Reviews/Drug Discovery 10 (2011) 809.
- 3
“Therapy deficit–studies to enhance psychological treatments are scandalously under-supported” (Sept. 2012),
Nature
489
(2012)
pp. 473–474.
10.1038/nature.2012.12164 Google Scholar
- 4 WHO Press, Medicines used in depressive disorders, Geneva, Switzerland, 2009, Chap. 4, p. 19.
- 5 Depression: A Global Crisis; www.who.int/mental_health/management/depression (accessed: 24 June 2013).
- 6 S.C. Sweetman (ed.): Martindale: The Complete Drug Reference, 35th ed., Pharmaceutical Press, London 2007, pp. 333–389.
- 7 R.J. Baldessarini: “ Drugs and the Treatment of Psychiatric Disorders, Depression and Anxiety Disorders,” in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th ed., McGraw-Hill, New York 2001, pp. 447–483.
- 8 G. Sanacora, C.A. Zarate, J.H. Krystal, H.K. Manji, Nature Reviews/Drug Discovery 7 (2008) 426–437.
- 9 W. Schindler, F. Haefliger, Helv. Chim. Acta 37 (1954) 472.
- 10 Geigy, US 2554736, 1951; CH-prior. 1949.
- 11 J. Thiele, O. Holzinger, Liebigs Ann. Chem. 305 (1899) 96.
- 12 Geigy, US 2764580, 1956; CH-prior. 1954.
- 13 Geigy, US 3515785, 1970; CH-prior.1958.
- 14 Geigy, US 3467650, 1969; CH-prior. 1958, 1959.
- 15 Geigy, US 2800470, 1957; CH-prior. 1954.
- 16 Geigy, US 3056774, 1962; CH-prior. 1958.
- 17 Geigy, US 3056776, 1962; CH-prior. 1959.
- 18 E. Kitamura et al., US 4013639, 1977; JP-prior. 1972.
- 19 P.N. Craig et al., J. Org. Chem. 26 (1961) 135.
- 20 Geigy, US 3449324, 1969; CH-prior. 1964.
- 21 H. Beschke, W.A. Schuler, US 3531466, 1970; DE-prior. 1965.
- 22 Geigy, DE 1132556, 1963; CH-prior. 1958.
- 23 Geigy, DE 1133729, 1963; CH-prior. 1957.
- 24 Taro Pharmaceutical, US 5599929, 4.2.1997; US-prior. 9.11.1994.
- 25 Rhone-Poulenc, FR 1172014, 1959; FR-prior. 1955.
- 26 R.M. Jacob, M. Messer, C.R. Hebd. Seances Acad. Sci. 252 (1961) 2117.
- 27 R.D. Hoffsommer et al., J. Org. Chem. 27 (1962) 4134.
- 28 Merck & Co., BE 584061; USA-prior. 1958.
- 29 Hoffmann-La Roche, GB 858186, 1961; CH-prior. 1958.
- 30 Hoffmann-La Roche, GB 858187, 1961; CH-prior. 1958.
- 31 Kefalas A/S, BE 609095; DK-prior. 1960.
- 32 A.C. Cope, S.W. Fenton, J. Am. Chem. Soc. 73 (1951) 1673.
- 33 Kefalas A/S, FR 1345936, 1963; GB-prior. 1962.
- 34 Geigy, DE 1288599, 1969; CH-prior. 1961.
- 35 Boehringer Mannheim, DE 1232161, 1967; DE-prior. 1961.
- 36 Boehringer Mannheim, US 3438981, 1969; DE-prior. 1963.
- 37 Pfizer, US 3420851, 1969; US-prior. 1962.
- 38 American Cyanamid, US 3681357, 1972; US-prior. 1964.
- 39 American Cyanamid, US 3663696, 1972; US-prior. 1964.
- 40 American Cyanamid, US 3 444 169, 1969; US-prior. 1966.
- 41 J. Schmutz et al., Helv. Chim. Acta 50 (1967) 245.
- 42 Ciba, US 3399201, 1968; CH-prior. 1960.
- 43 Ciba, US 3632653, 1972; CH-prior. 1960.
- 44 H. Wilhelm, P. Schmidt, Helv. Chim. Acta 52 (1969) 1385.
- 45 Dumex A/S, US 3299139, 1967; GB-prior. 1963.
- 46 D.W. Robertson et al., J. Med. Chem. 31 (1988) 1412.
- 47 Lilly, US 4018895, 1974; US-prior. 1974.
- 48 Lilly, US 4194009, 1980; US-prior. 1974.
- 49 Lilly, US 4314081, 1982; US-prior. 1974.
- 50 D.D. Wirth, M.S. Miller, S.K. Boini, T.M. Koenig, OPRD 4 (2000) 513.
- 51 Novo Nordisk, US 5019592, 1991; DK-prior. 1987.
- 52 Pliva, US 5618968, 1997; Croatia-prior. 1993.
- 53 A.J. Bigler et al., Eur. J. Med. Chem. 12 (1977) 289.
- 54 Kefalas A/S, US 4136193, 1979; GB-prior. 1976.
- 55 Lundbeck A/S, US 4650884, 1987; GB-prior. 1984.
- 56 Lundbeck A/S, US 6855834, 2005; DK-prior. 2000.
- 57 Lundbeck, US 4943590, 1990; GB-prior. 1988.
- 58 Ferrosan, US 3912743, 1975; GB-prior. 1973.
- 59 Ferrosan, US 4007196, 1977; GB-prior. 1973.
- 60 SmithKline Beecham, US 6172233, 2001; GB-prior. 1997.
- 61 G. de Gonzalo, R. Brieva, V.M. Sánchez, M. Bayod, V. Gotor, J. Org. Chem. 66 (2001) 8947.
- 62
S. Brandau,
A. Landa,
J. Franzén,
M. Marigo,
K. Anker Jørgensen,
Angew. Chem.
118
(2006)
4411.
10.1002/ange.200601025 Google Scholar
- 63 Beecham, US 4861893, 1989; GB-prior. 1985.
- 64 W.M. Welch et al., J. Med. Chem. 27 (1984) 1508.
- 65 Pfizer, US 4536518, 1985; US-prior. 1979.
- 66 G.P. Taber, D.M. Pfisterer, J.C. Colberg, OPRD 8 (2004) 385.
- 67 Delalande S.A., EP 346226, 1993; FR-prior. 1988.
- 68 Philips Corp., US 4085225, 1978; NL-prior. 1975.
- 69 Smith Kline & French, US 2997422, 1961; US-prior. 1959.
- 70 A. Burger, W.L. Yost, J. Am. Chem. Soc. 70 (1948) 2198.
- 71 Nelson Research & Development, US 4016204, 1977; US-prior. 1975.
- 72 Hoffmann-La Roche, GB 1512194, 1978; AT-prior. 1976.
- 73 Hoffmann-La Roche, US 4210754, 1980; US-prior. 1977.
- 74 W.J. Van der Burg et al., J. Med. Chem. 13 (1970) 35.
- 75 Organon, US 3534041, 1970; NL-prior. 1966.
- 76 HZI Research Center, N.Y., USA, US 4128641, 1978; USA-prior. 1975 (medical use).
- 77 Akzona Inc., US 4217452, 1980; NL-prior. 1974.
- 78 Akzona Inc., US 4254031, 1981; NL-prior. 1974.
- 79 Akzona Inc., US 4062848, 1977; NL-prior. 1975.
- 80 Teva, US 6339156, 2002; US-prior. 1999.
- 81 Sumika Fine Chemicals, US 6495685, 2002; JP-prior. 1999.
- 82 Sumika Fine Chemicals, US 6437120, 2002; JP-prior. 1999.
- 83 Organon, US 8058436, 2011; EP-prior. 2003.
- 84 Angelini Francesco, US 3381009, 1968; IT-prior. 1965.
- 85 Angelini Francesco, US 8314236, 2012; IT-prior. 2007.
- 86 Burroughs Wellcome, US 3819706, 1974; GB-prior. 1969.
- 87 American Home Products, US 4535186, 1985; US-prior. 1982.
- 88 J.P. Yardley et al., J. Med. Chem. 33 (1990) 2899.
- 89 M. Saravanan, B. Satyanarayana, P.P. Reddy, OPRD 15 (2011) 1392.
- 90 Farmitalia Carlo Erba, US 4229449, 1980; IT-prior. 1978.
- 91 P. Melloni et al., Tetrahedron 41 (1985) 1393.
- 92 K.E. Henegar, C.T. Ball, C.M. Horwath, K.D. Maisto, S.E. Mancini, OPRD 11 (2007) 346.
- 93 Pfizer, US 7659394, 2010; US-prior. 2004.
- 94 K.E. Henegar, M. Cebula, OPRD 11 (2007) 354.
- 95 S.T. Hayes, G. Assaf, G. Checks Field, C. Cheung et al., OPRD 15 (2011) 1305.
- 96 A.B. Waitekus, P. Kirkpatrick, Nature Reviews/Drug Discovery 3 (2004) 907.
- 97 Eli Lilly, US 4956388, 1990; US-prior. 1986.
- 98 Eli Lilly, US 5023269, 1991; US-prior. 1986.
- 99 Eli Lilly, US 5362886, 1994; US-prior. 1993.
- 100 Eli Lilly, US 5491243, 1996; US-prior. 1993.
- 101 Y. Fujima, M. Ikunaka, T. Inoue, J. Matsumoto, OPRD 10 (2006) 905.
- 102 S. Suthrapu, S. Sripathi, R. Veeramalla, R.R. Bojja, V.R. Karnati, OPRD 13 (2009) 854.
- 103 J. Majer, P. Kwiatkowski, J. Jurczak, Org. Lett. 11 (2009) 4636.
- 104 Y. Suzuki, M. Iwata, R. Yazaki, N. Kumagai, M. Shibasaki, J. Org. Chem. 77 (2012) 4496.
- 105 BASF, US 7435563, 2008; DE-prior. 2002.
- 106 C. de Bodinat, B. Guardiola-Lemaitre, E. Mocaër, P. Renard, C. Muñoz, M.J. Millan, Nature Reviews/Drug Discovery 9 (2010) 628.
- 107 Adir, US 5194614, 1993; FR-prior. 1990.
- 108 Adir, US 5225442, 1993; FR-prior. 1990.
- 109 Servier, US 7476751, 2009; FR-prior. 2004.
- 110 Servier, US 8329947, 2012; FR-prior. 2008.
- 111 Z. Hamersak, A. Avdagic, US 2010016638; US-prior. 2008.
- 112 Merck, US 5532241, 1996; DE-prior. 1993.
- 113 T. Heinrich, H. Böttcher, G.D. Bartoszyk, H.E. Greiner, C.A. Seyfried, C. van Amsterdam, J. Med. Chem. 47 (2004) 4684.
- 114 B. Hu, Q. Song, Y. Yu, OPRD 16 (2012) 1552.
- 115 Merck, US 7799916, 2010; DE-prior. 2005.
- 116 Merck, US 7834020, 2010; EP-prior. 2001.
